Skip to content

A Hospital Based Survey on Lung Cancer Related-pain in Northern China

Clinical Characteristics, Evaluation and Management of Lung Cancer Related-pain in Northern China: a Hospital-based Cross-sectional Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03189277
Enrollment
2000
Registered
2017-06-16
Start date
2017-06-30
Completion date
2017-09-30
Last updated
2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain, Lung Cancer

Brief summary

This cross-sectional study, utilizing two sets of questionaire designed for patients and physicians respectively, aims at the epidemiology, the clinical features, and the current status of evaluation and management of lung cancer related pain in 20 participating hospitals in Northern China.

Detailed description

Lung malignancies have become the most common cause of mortality among patients with cancer in China. A significant proportion of lung cancer patients suffer from cancer related pain, however few studies have reported the prevalence and clinical features of such pain, especially in China. This study is a cross-sectional survey in 20 hospitals in Northern China. We designed two separate series of questions to be answered by patients and cancer management professionals. In the patient questionaire, we collect information on the prevalence, location, intensity, impact on life of lung cancer related pain. Questions on how doctors evaluate and manage the pain are included in both the patients' and physicians' surveys. In the doctors' questionaire, we also assess current situation of cancer pain educational programs attended in medical schools and post graduation through related questions.

Interventions

None listed

Sponsors

Peking University Cancer Hospital & Institute
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
Beijing Chest Hospital
CollaboratorOTHER
307 Hospital of PLA
CollaboratorOTHER
Peking Union Medical College Hospital
CollaboratorOTHER
Beijing Chao Yang Hospital
CollaboratorOTHER
Peking University Third Hospital
CollaboratorOTHER
Peking University First Hospital
CollaboratorOTHER
The Hospital of Shunyi District Beijing
CollaboratorUNKNOWN
Daxing Hospital Beijing
CollaboratorUNKNOWN
Peking University Third Hospital Yanqing Hospital
CollaboratorUNKNOWN
Tianjin Medical University Cancer Institute and Hospital
CollaboratorOTHER
Tianjin Medical University General Hospital
CollaboratorOTHER
Hebei Medical University Fourth Hospital
CollaboratorOTHER
Henan Cancer Hospital
CollaboratorOTHER_GOV
Shanxi Province Cancer Hospital
CollaboratorOTHER
Inner Mongolia People's Hospital
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
309th Hospital of Chinese People's Liberation Army
CollaboratorOTHER
Chinese Academy of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. The patient questionaire * All patients (outpatient and inpatient) diagnosed with lung cancer visiting the participating hospitals on the designated day of investigation * Informed consent must be obtained from the participating patients 2. The physician questionaire * All physicians who receive lung cancer patients (outpatient and inpatient) in the participating hospitals on the designated day of investigation

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of cancer-related pain in lung cancer patients in 20 hospitals in northern China24 hoursthe proportion of self-reported pain related to cancer affecting the enrolled lung cancer patients over the past 24 hours

Contacts

Primary ContactYuankai Shi, MD
syuankaipumc@126.com86-10-87788293
Backup ContactBo Zhang, MD
zh.bo@outlook.com86-10-87787447

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026